Which document confirms that the site is suitable for the trial?

• A. Pre-Trial Monitoring Report
• B. Master Randomization List
• C. Investigator's Brochure Updates
• D. Any Revision to Trial Documents

Answer: (A)

Assessing whether a site is ready to conduct a trial relies on documenting the site's qualification and readiness, typically captured in the pre-trial monitoring report. This document records the findings from the pre-study visit, including facilities, equipment, staff qualifications and training, SOPs, regulatory approvals, and the site’s ability to follow the protocol and protect participants. It serves as formal confirmation that the site meets the requirements to enroll and manage the trial.

A master randomization list is used for assigning participants to treatment arms and is not a tool for verifying site readiness. Investigator’s brochure updates convey information about the investigational product, not the site’s capability. Revisions to trial documents may occur during the study but do not constitute a validation of the site’s suitability.